Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antituberculous immunity: new solutions to an old problem.

F M Collins1

  • 1Trudeau Institute, Inc., Saranac Lake, New York 12983.

Reviews of Infectious Diseases
|September 1, 1991
PubMed
Summary

New tuberculosis vaccines are needed. Advances in genetic engineering allow for the development of tailored vaccines using Mycobacterium tuberculosis genes to protect against various forms of the disease.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Giant Dermoid Cyst.

The Indian medical gazette·2017
Same author

The Treatment of Cervical Glandular Tuberculosis.

The Indian medical gazette·2017
Same author

Adherent Fallopian Tube Causing Intestinal Strangulation.

British medical journal·2010
Same author

'Rescue' of mini-genomic constructs and viruses by combinations of morbillivirus N, P and L proteins.

The Journal of general virology·2005
Same author

Susceptibility of mice deficient in the MHC class II transactivator to infection with Mycobacterium tuberculosis.

Scandinavian journal of immunology·2003
Same author

Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products.

Tuberculosis (Edinburgh, Scotland)·2001

Area of Science:

  • Microbiology
  • Immunology
  • Biotechnology

Background:

  • Tuberculosis (TB) remains a significant global health issue, particularly affecting vulnerable populations in Europe and the US.
  • Existing antituberculosis treatments face challenges, highlighting the urgent need for novel prophylactic and therapeutic vaccines.
  • TB disproportionately impacts the elderly, individuals with substance abuse issues, immigrants from endemic regions, and those with Acquired Immunodeficiency Syndrome (AIDS).

Purpose of the Study:

  • To explore the development of new antituberculosis vaccines.
  • To leverage molecular biology and genetic engineering for improved vaccine design.
  • To create specifically tailored vaccines for diverse populations and disease forms.

Main Methods:

  • Utilizing advances in molecular biology, genetic engineering, and hybridoma technology.
  • Identifying and cloning genes responsible for protective antigens (epitopes) of Mycobacterium tuberculosis.
  • Employing shuttle phasmids to transfer these "protective" genes into expression vectors.

Main Results:

  • The study outlines a method for developing specifically tailored vaccines.
  • The approach allows for the targeted production of protective antigens from Mycobacterium tuberculosis.
  • This facilitates the creation of vaccines designed for enhanced efficacy.

Conclusions:

  • Molecular biology and genetic engineering offer a promising pathway for developing next-generation antituberculosis vaccines.
  • Tailored vaccines can potentially offer improved protection against both pulmonary and disseminated forms of tuberculosis.
  • This strategy holds promise for protecting vulnerable populations, including infants, young adults, and immunocompromised individuals.

Related Experiment Videos